Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.

Revenue
+0.55%
EPS
−85.0%
Free cash flow
+154.2%
Total debt
−4.96%

Quarter to September 2026, against a year earlier

30.43 0.08 −0.26%
Market cap
$29.8B
P/E
25.8×
Fwd P/E
11.2×
Dividend yield
3.33%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100

Koninklijke Philips N.V. (PHG) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Koninklijke Philips N.V. (PHG) trades at a P/B ratio of 2.2×. Over the past ten years it has ranged from 0.6× (November 2022) to 3.8× (December 2020); the current reading is higher than 62% of that period. That is below the Medical Devices industry median of 2.5× and in line with the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 2.1× 12.19%
FY2024 1.8× 18.44%
FY2023 1.6× 64.28%
FY2022 0.9× (49.93%)
FY2021 1.9× (41.62%)
FY2020 3.2× 10.49%
FY2019 2.9× 36.05%
FY2018 2.2× (6.46%)
FY2017 2.3× 34.22%
FY2016 1.7× (3.76%)

Quarterly newest first

Period P/B ratio Change
Sep 2026 1.8× (8.20%)
Jun 2026 1.9× (0.22%)
Mar 2026 2.0× (5.53%)
Dec 2025 2.1× (1.41%)
37 more quarters

Against its own ten years

Low 0.6× High 3.8×
Ten-year median 2.0×
Current reading's percentile 58

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on PHG